Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Pathogens | Free Full-Text | Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure? - Asselah - 2018 - Liver International - Wiley Online Library
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice
Mechanism of Action of Direct-Acting Antivirals: New Insights into the HCV Life Cycle | SpringerLink
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article
Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus | SpringerLink
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting - ScienceDirect
Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis - eClinicalMedicine
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection – Dr. Leonardo Riella
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients | PLOS ONE
Direct-Acting Antiviral Drugs For The Treatment Of Hepatitis C
Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study | Bentham Science
Ausgabe 1/2016: HIV/HCV Koinfektion Pharmakologie der neuen Direct Acting Antivirals
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
SciELO - Brasil - Recurrence of hepatitis C virus after treatment with pegylated interferon and direct acting antivirals in Punjab Pakistan Recurrence of hepatitis C virus after treatment with pegylated interferon and
JPM | Free Full-Text | Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications | PLOS ONE
Frontiers | Current and Future Direct-Acting Antivirals Against COVID-19
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019 - eClinicalMedicine
Direct Acting Antivirals for Pandemic Prevention - Milwaukee Institute for Drug Discovery
Viruses | Free Full-Text | Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
